Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders
Lauri M. Burroughs(Fred Hutch Cancer Center), Ann E. Woolfrey(University of Washington), Haydar Frangoul(Children’s Hospital at TriStar Centennial), Colleen Delaney(Seattle Children's Hospital), Jennifer Domm(Vanderbilt University), Eneida R. Nemecek(Oregon Health & Science University), Kelsey K. Baker(Fred Hutch Cancer Center), Akiko Shimamura(Harvard University), Brenda M. Sandmaier(University of Washington), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Julie‐An Talano(Dana-Farber Cancer Institute), K. Scott Baker(University of Washington), Amy E. Geddis(Seattle Children's Hospital), David A. Margolis(Medical College of Wisconsin), H. Joachim Deeg(Fred Hutch Cancer Center)
Cited by 51
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
|New England Journal of Medicine|2020|1.8k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k